Form 4: H.B. Fuller Executive VP and CFO, John J. Corkrean, Reports Changes in Beneficial Ownership
SEC Form 4 Filing
John J. Corkrean, Executive VP and CFO of H.B. Fuller, filed a Form 4 detailing changes in his beneficial ownership of the company's stock and derivative securities.
Summary
- On April 25, 2025, John J. Corkrean, Executive VP and CFO of H.B. Fuller, reported changes in his beneficial ownership of the company's securities.
- The filing includes transactions related to phantom units, employee stock options, and restricted stock units.
- Corkrean directly owns 52,196 shares of H.B. Fuller common stock.
- He also holds various employee stock options with exercise prices ranging from $43.48 to $77.72 and expiration dates between 2026 and 2035.
- Additionally, Corkrean possesses restricted stock units that convert into common stock on a 1-for-1 basis and vest in three annual installments.
- The reported transactions include the acquisition of 172.73 phantom units.
Sentiment
Score: 5
Explanation: This is a routine filing, and the information presented doesn't inherently indicate positive or negative sentiment. It simply reflects changes in the executive's holdings.
Positives
- The reporting person continues to hold a significant number of shares and derivative securities, indicating continued investment in the company's future.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.
Comparison to Industry Standards
- Executive compensation packages, including stock options and restricted stock units, are common across publicly traded companies.
- The vesting schedules and exercise prices of the options appear to be within typical ranges for similar roles in comparable companies.
- Comparing the total equity holdings of Mr. Corkrean to those of CFOs at peer companies like Avery Dennison or 3M would provide a more comprehensive assessment of his stake in H.B. Fuller.
Stakeholder Impact
- The filing provides transparency to shareholders regarding the executive's stake in the company.
- It can influence investor perception of management's alignment with shareholder interests.
Key Dates
| Date | Description |
|---|---|
| 05/17/2017 | Date of grant for employee stock options with an exercise price of $43.48 and an expiration date of 05/17/2026. |
| 01/26/2018 | Date of grant for employee stock options with an exercise price of $50.1 and an expiration date of 01/26/2027. |
| 01/25/2019 | Date of grant for employee stock options with an exercise price of $53.57 and an expiration date of 01/25/2028. |
| 01/24/2020 | Date of grant for employee stock options with an exercise price of $45.05 and an expiration date of 01/24/2029. |
| 01/24/2021 | Date of grant for employee stock options with an exercise price of $48.35 and an expiration date of 01/24/2030. |
| 01/27/2022 | Date of grant for employee stock options with an exercise price of $51.89 and an expiration date of 01/27/2031. |
| 01/24/2023 | Date of grant for employee stock options with an exercise price of $72.94 and an expiration date of 01/24/2032. |
| 01/24/2024 | Date of grant for employee stock options with an exercise price of $68.17 and an expiration date of 01/24/2033, and the vesting start date for restricted stock units expiring on 01/24/2026. |
| 01/26/2025 | Date of grant for employee stock options with an exercise price of $77.72 and an expiration date of 01/26/2034, and the vesting start date for restricted stock units expiring on 01/26/2027. |
| 01/27/2026 | Date of grant for employee stock options with an exercise price of $64.28 and an expiration date of 01/27/2035, and the vesting start date for restricted stock units expiring on 01/27/2028. |
| 04/25/2025 | Date of the reported transaction involving phantom units. |
| 04/28/2025 | Date of signature for the Form 4 filing. |
Keywords
Form 4, beneficial ownership, H.B. Fuller, stock options, restricted stock units, phantom units, securities, executive compensation, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.